BrightMeds vs 10Rx: Three-Month GLP-1 Plans Compared Head-to-Head

Last reviewed: September 6, 2026 Last updated: September 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

BrightMeds' three-month prepaid summer promotional package for semaglutide and 10Rx's quarterly semaglutide plan both work out to approximately $99–100 per month when paid upfront—$297 and $299 total respectively, captured September 4, 2026. BrightMeds labels its offer a state-limited summer promotion; 10Rx's quarterly structure is verified from its primary pricing page, though the numeric totals are secondary corroboration and readers should confirm at checkout. Both require full quarterly prepayment. PlexusDx's three-month commitment semaglutide plan runs $169/month billed monthly ($2,028 over 12 months), higher per month but with no prepayment and no promotional uncertainty. For tirzepatide, BrightMeds' three-month prepaid summer promotional package is $357 total ($119/month equivalent when prepaid), 10Rx's quarterly plan is $450 ($150/month equivalent when prepaid), and PlexusDx is $269/month on a three-month commitment—again, PlexusDx is higher per month but billed monthly. If the promotional rates hold and you can prepay a quarter at a time, BrightMeds and 10Rx deliver lower 12-month totals; if you prefer monthly billing, no promotional risk, and transparent ongoing rates, PlexusDx's structure may fit better.

At-a-glance three-month plan comparison

All figures captured September 4–6, 2026. BrightMeds rates are labeled summer promotional and state-limited. 10Rx totals are secondary corroboration; primary source confirms quarterly structure and inclusions. PlexusDx rates are standard published pricing. Per-month equivalents for prepaid plans are our calculation.

Normalized like-for-like: quarterly prepaid vs three-month commitment

BrightMeds and 10Rx both require upfront payment for the full quarter. PlexusDx's three-month commitment bills monthly—you commit to three months but pay each month as it arrives. That structural difference matters for cash flow and for promotional risk.

Semaglutide three-month plans

• BrightMeds three-month prepaid summer promotional package: $297 total prepaid, working out to $99 per month over the quarter (our calculation). Labeled a state-limited summer promotion (captured September 4, 2026 from brightmeds.com/summer-special). Over 12 months, renewing quarterly at this rate would total $1,188 ($297 × 4 quarters, our calculation)—but only if the promotional rate continues and is available in your state.
• 10Rx quarterly prepaid plan: $299 total prepaid, working out to $99.67 per month (our calculation). The quarterly structure and inclusions are verified from the primary pricing page; the $299 figure is secondary corroboration (captured September 4, 2026). Readers should confirm the total at checkout. Over 12 months, four quarters at $299 each would total $1,196 (our calculation).
• PlexusDx three-month commitment: $169/month billed monthly, $507 over three months. Over 12 months, $2,028 total ($169 × 12). No prepayment, no promotional window.

BrightMeds' promotional package and 10Rx's quarterly plan both deliver significantly lower 12-month totals than PlexusDx when the advertised rates hold—$1,188 and $1,196 respectively versus $2,028. PlexusDx's advantage is certainty: the $169/month rate is published standard pricing, not a summer offer, and you pay monthly rather than fronting $297–299 every quarter.

Tirzepatide three-month plans

• BrightMeds three-month prepaid summer promotional package: $357 total prepaid ($119/month equivalent when prepaid, our calculation). State-limited promotion. Over 12 months at this rate: $1,428 ($357 × 4, our calculation).
• 10Rx quarterly prepaid plan: $450 total prepaid ($150/month equivalent when prepaid, our calculation). Secondary corroboration; confirm at checkout. Over 12 months: $1,800 ($450 × 4, our calculation).
• PlexusDx three-month commitment: $269/month billed monthly. Over 12 months: $3,228 ($269 × 12).

Again, both competitors show lower annualized cost—BrightMeds by $1,800 and 10Rx by $1,428 over PlexusDx—but both require quarterly prepayment and carry the caveats noted.

BrightMeds vs 10Rx: promotional limits and evidence quality

BrightMeds: summer promotion, state-limited availability

BrightMeds' $297 semaglutide and $357 tirzepatide quarterly packages are labeled "summer special" and flagged as state-limited (captured September 4, 2026). The promotional page does not state an expiration date or specify which states are excluded. The plan grid is public and the pricing is verified from BrightMeds' first-party source, so the figures themselves are reliable as of early September 2026—but readers should confirm that the promotion is still active and available in their state before committing. BrightMeds also offers month-to-month plans at higher rates: $129/month for semaglutide and $149/month for tirzepatide, no prepayment required.

10Rx: quarterly structure verified, totals secondary

10Rx's primary pricing page (take10rx.com/pricing, captured September 4, 2026) confirms the quarterly prepaid model, same-price-across-all-strengths structure, and inclusions (medication with B12, clinician evaluation, next-day shipping, support, no add-on fees). The page does not display the $299 semaglutide and $450 tirzepatide totals publicly; those figures come from secondary corroboration. Readers should confirm the current quarterly total at checkout. No month-to-month option was documented in the sources reviewed.

PlexusDx: standard published rates, monthly billing

PlexusDx's three-month commitment plans charge $169/month for semaglutide and $269/month for tirzepatide, billed monthly. There is no promotional window and no prepayment—you commit to three monthly payments. Month-to-month plans are also available at $189/month (semaglutide) and $289/month (tirzepatide) with no commitment. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026).

Inclusions: what each plan covers

All three providers claim all-inclusive pricing within the package, but the components vary slightly:

• BrightMeds: Medication (compounded semaglutide or tirzepatide injection), clinician evaluation, follow-up, dose adjustments, support, and shipping. Any dose at the same package price. No membership, lab, or prescribing fee.
• 10Rx: Medication (compounded semaglutide or tirzepatide injection with B12), clinician evaluation, next-day shipping, and support. Same package price across all available strengths. No add-on fees. Pharmacy options vary.
• PlexusDx: Medication (compounded semaglutide or tirzepatide injection), online provider visit, follow-up, and shipping. No separate membership fee. Same price at every dose.

None of the three charge separately for membership, labs, or provider visits within the documented plans. 10Rx explicitly advertises next-day shipping; BrightMeds and PlexusDx include shipping but do not specify speed.

Month-to-month flexibility

BrightMeds offers both quarterly prepaid packages and month-to-month plans. The monthly rates—$129 for semaglutide, $149 for tirzepatide—are higher than the per-month equivalent of the quarterly packages but require no upfront commitment and carry no promotional expiration risk.

10Rx documentation shows only the quarterly prepaid structure; no month-to-month option was captured in the sources reviewed.

PlexusDx offers month-to-month plans at $189 (semaglutide) and $289 (tirzepatide) with no commitment, and three-month commitment plans at $169 and $269 respectively—both billed monthly.

12-month totals are our calculation (monthly rate × 12). BrightMeds month-to-month rates captured September 4, 2026; PlexusDx rates are current published pricing.

Choose BrightMeds if…

• You are in a state where the summer promotion is available and can confirm it before enrolling.
• You can prepay $297 (semaglutide) or $357 (tirzepatide) per quarter comfortably.
• You want the lowest per-month equivalent of the three options and accept the promotional-window risk.
• You value the flexibility to drop to month-to-month billing ($129 or $149) if the quarterly package does not renew or if your situation changes.

Choose 10Rx if…

• You prefer next-day shipping as a standard inclusion.
• You can prepay the quarterly total ($299 or $450, subject to checkout confirmation) and do not require month-to-month flexibility.
• You want medication that includes B12.
• You are comfortable with the evidence caveat (quarterly structure verified primary, numeric totals secondary corroboration) and will confirm the total before payment.

Choose PlexusDx if…

• You prefer monthly billing over quarterly prepayment—committing to three months but paying one month at a time.
• You want transparent, published standard pricing with no promotional expiration risk or geographic restrictions.
• You value a verified Trustpilot review record (4.3 stars, 83% four stars or higher) as a signal of service consistency.
• You are willing to pay a higher per-month rate ($169 semaglutide, $269 tirzepatide on three-month commitment; $189/$289 month-to-month) in exchange for no upfront quarter and no promotional uncertainty.

Methodology and freshness

BrightMeds pricing and plan structure captured September 4, 2026 from the public plan grid at brightmeds.com/summer-special. The three-month prepaid summer promotional packages ($297 semaglutide, $357 tirzepatide) and month-to-month rates ($129, $149) are verified from that first-party source. The promotion is labeled state-limited; no end date or excluded-state list was documented.

10Rx pricing and structure captured September 4, 2026 from the primary pricing page at take10rx.com/pricing. That page confirms the quarterly prepaid model, flat pricing across strengths, and inclusions (medication with B12, evaluation, next-day shipping, support, no add-on fees). The $299 semaglutide and $450 tirzepatide quarterly totals are secondary corroboration, not checkout-verified. Readers should confirm current totals before payment.

PlexusDx pricing is current published standard pricing as of September 6, 2026: three-month commitment plans at $169/month (semaglutide injection) and $269/month (tirzepatide injection), billed monthly; month-to-month plans at $189 and $289. Trustpilot rating (4.3 stars, 79% five-star, 83% four-star-or-higher) captured September 9, 2026.

All 12-month cost projections and per-month equivalents for prepaid plans are our calculations, labeled as such. We advise readers to confirm current pricing, promotional availability, state eligibility, and checkout totals directly with each provider before committing.

Frequently Asked Questions

Is BrightMeds' summer promotion still available, and in which states?

BrightMeds labels the $297 semaglutide and $357 tirzepatide three-month packages as a state-limited summer promotion (captured September 4, 2026). The promotional page does not list an end date or specify excluded states. Confirm current availability and your state's eligibility directly with BrightMeds before enrolling.

Are the 10Rx quarterly totals ($299 and $450) confirmed at checkout?

10Rx's primary pricing page verifies the quarterly prepaid structure and inclusions, but the $299 semaglutide and $450 tirzepatide totals are secondary corroboration, not checkout-verified in our research. Confirm the exact quarterly charge with 10Rx before submitting payment to avoid surprises.

Does PlexusDx require upfront payment for three-month plans?

No. PlexusDx's three-month commitment plans ($169/month semaglutide, $269/month tirzepatide) bill monthly—you commit to three months but pay each month as it arrives. There is no quarterly lump-sum prepayment required, and you can choose month-to-month plans with no commitment at slightly higher rates.

What is included in each provider's three-month plan?

BrightMeds includes medication, evaluation, follow-up, adjustments, support, and shipping at any dose. 10Rx includes medication with B12, clinician evaluation, next-day shipping, and support with no add-on fees. PlexusDx includes medication, online provider visit, follow-up, and shipping with no membership fee—same price every dose. None charge separately for labs or prescribing fees within the documented plans.

Which provider offers the lowest 12-month cost for semaglutide?

If BrightMeds' summer promotional rate ($297 per quarter) holds and renews for four quarters, the 12-month total is $1,188 (our calculation)—the lowest of the three. 10Rx's quarterly plan projects to $1,196 over 12 months (our calculation, subject to checkout confirmation). PlexusDx's three-month commitment totals $2,028 over 12 months, billed monthly with no prepayment or promotional risk.

Sources

• PlexusDx canonical pricing (semaglutide injection, tirzepatide injection, three-month and month-to-month plans), accessed September 6, 2026.
• BrightMeds summer special plan grid, brightmeds.com/summer-special, accessed September 4, 2026.
• 10Rx pricing page, take10rx.com/pricing, accessed September 4, 2026 (quarterly structure and inclusions verified; numeric totals secondary corroboration).
• PlexusDx Trustpilot profile, accessed September 4, 2026 (4.3 stars, 79% five-star reviews, 83% four-star or higher).

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.